The 43-year-old, who has won 23 Grand Slam titles and is the epitome of athleticism, admits that after having children, she struggled to shed the extra poundsjust like many of us
Phil McGraw
And it was originally developed, the GLP-1 receptor agonist, so the medication itself was originally developed for diabetics to help the body produce more insulin, reduce the amount of sugar, of blood sugar, I should say, which can be really bad for diabetics
While microdosing GLP-1s may be beneficial for a variety of reasons for certain individuals, the growing interest in microdosing GLP-1s can at least in part be tied to the significant metabolic shifts women experience during perimenopause and menopause
At Klinic, our care team alleviates the burden of navigating semaglutide insurance coverage